Drug-induced tardive syndromes
- PMID: 18591121
- DOI: 10.1016/s1353-8020(99)00015-2
Drug-induced tardive syndromes
Abstract
We reviewed the database of five Movement Disorders Units to establish drugs responsible for tardive syndromes or TS (tardive dyskinesia, dystonia, akathisia, tremor, tics or tourettism, and myoclonus). The diagnostic criteria for TS included: (1) appearance of persistent dyskinesia, dystonia, akathisia, tremor, tics or tourettism, or myoclonus, related to prolonged drug exposure, (2) exclusion of other possible causes of these movement disorders. One-hundred patients fulfilled the diagnostic criteria for TS (26 males, 74 females, mean age 69.4+/-15.8 years). TS were related to 1, 2, 3, 4 and 5 drugs in 58, 27, 9, 5 and 1 patients, respectively. The most frequently offending drugs were antipsychotic drugs, substituted benzamides, thietylperazine and calcium-channel blockers. Seventy-two patients had buccolinguomasticatory syndrome, 30 had tremor, 22 akathisia and 16 dystonia (35 patients had a combination of at least two of these TS). Forty-two patients had coexistent parkinsonism. The TS disappeared following withdrawal of the offending drug in 40 cases. Old age and being female were more frequently associated with TS, with the exception of tardive dystonia. Substituted benzamides, calcium-channel blockers and thiethylperazine (a neuroleptic used for vertigo) were a frequent cause of TS in our series.
Similar articles
-
The nosology of tardive syndromes.J Neurol Sci. 2018 Jun 15;389:10-16. doi: 10.1016/j.jns.2018.02.008. Epub 2018 Feb 6. J Neurol Sci. 2018. PMID: 29433810
-
Drug-induced parkinsonism in a movement disorders unit: A four-year survey.Parkinsonism Relat Disord. 1996 Jul;2(3):145-9. doi: 10.1016/1353-8020(96)00013-2. Parkinsonism Relat Disord. 1996. PMID: 18591033
-
Drug-induced movement disorders.Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004. Drug Saf. 1997. PMID: 9098656 Review.
-
Classification and treatment of tardive syndromes.Neurologist. 2003 Jan;9(1):16-27. doi: 10.1097/01.nrl.0000038585.58012.97. Neurologist. 2003. PMID: 12801428 Review.
-
[Orthostatic tremor induced by pharmaceuticals].Rev Neurol. 2004 Nov 1-15;39(9):834-6. Rev Neurol. 2004. PMID: 15543499 Spanish.
Cited by
-
Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.Toxins (Basel). 2022 Apr 14;14(4):282. doi: 10.3390/toxins14040282. Toxins (Basel). 2022. PMID: 35448891 Free PMC article. Review.
-
A Pharmacogenetic Discovery: Cystamine Protects Against Haloperidol-Induced Toxicity and Ischemic Brain Injury.Genetics. 2016 May;203(1):599-609. doi: 10.1534/genetics.115.184648. Epub 2016 Mar 18. Genetics. 2016. PMID: 26993135 Free PMC article.
-
Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering.Front Psychiatry. 2021 Oct 25;12:683368. doi: 10.3389/fpsyt.2021.683368. eCollection 2021. Front Psychiatry. 2021. PMID: 34759847 Free PMC article.
-
An update on the diagnosis and treatment of Parkinson disease.CMAJ. 2016 Nov 1;188(16):1157-1165. doi: 10.1503/cmaj.151179. Epub 2016 May 24. CMAJ. 2016. PMID: 27221269 Free PMC article. Review. No abstract available.
-
Drug-Induced Myoclonus: A Systematic Review.Medicina (Kaunas). 2025 Jan 15;61(1):131. doi: 10.3390/medicina61010131. Medicina (Kaunas). 2025. PMID: 39859113 Free PMC article.
LinkOut - more resources
Full Text Sources